Singer Capital Markets appointed as Nominated Adviser & Broker to Mereo BioPharma Group plc

Singer Capital Markets is pleased to announce our appointment as Nominated Adviser and Broker to Mereo BioPharma Group plc with immediate effect.

About Mereo BioPharma Group plc

Mereo BioPharma is a biopharmaceutical company focused on the development and commercialization of innovative therapeutics that aim to improve outcomes for patients with oncology and rare diseases. Mereo’s strategy is to selectively acquire product candidates for oncology and rare diseases that have already received significant investment from pharmaceutical and large biotechnology companies and that have substantial preclinical, clinical and manufacturing data packages.

Ticker: MPH (AIM)
Market Cap: £150.7 million*
Website: Click here

*As at 06/08/2020